BioSante Pharmaceuticals, Inc. (BPAX)

[Just the facts maam]

Two CV Patent Applications regarding Libigel (January 2012)

Methods for treating sexual dysfunction while decreasing cardiovascular risk

Abstract
Methods for treating female sexual dysfunction are provided. In particular, methods for treating a woman having HSDD by administering to the woman a therapeutically effective amount of an androgen, whereby the therapeutically effective amount of the androgen is administered in a manner that results in a reduction in expected number of cardiovascular events in the woman are provided.

Methods for decreasing cardiovascular risk in postmenopausal women

Abstract
Methods for decreasing the risk of cardiovascular events in postmenopausal women having a high risk for a cardiovascular event are provided. In particular, methods for decreasing the risk of cardiovascular events in postmenopausal woman at high risk for cardiovascular events by administering to the woman a therapeutically effective amount of an androgen, whereby administering the androgen decreases the risk of cardiovascular events in the woman compared to untreated postmenopausal woman at high risk for cardiovascular events are provided.